Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT ID: NCT00248170
Last Updated: 2016-04-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
4172 participants
INTERVENTIONAL
2005-12-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
NCT00553410
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00004205
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
NCT00530868
Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
NCT00107016
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
NCT00171847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Letrozole
2.5 mg by mouth (p.o.) once daily
Letrozole
2.5 mg tablets
Anastrozole
1 mg p.o. once daily
Anastrozole
1 mg tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Letrozole
2.5 mg tablets
Anastrozole
1 mg tablets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Early stage breast cancer
* Postmenopausal
* Hormone receptor positive
* Positive lymph node involvement
Exclusion Criteria
* Presence of contralateral breast cancer including DCIS
* Progression
33 Years
96 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Hematology and Oncology Associates
Birmingham, Alabama, United States
Comprehensive Cancer Institute
Huntsville, Alabama, United States
Northern Arizona Hematology/Oncology Associates, P.C.
Flagstaff, Arizona, United States
Oncology & Hematology Associates, PC
New London, Connecticut, United States
Florida Cancer Specialists
Fort Meyers, Florida, United States
Sarah Cannon Research Institute
Jacksonville, Florida, United States
Cancer Centers of Florida PA
Ocoee, Florida, United States
Florida Cancer Institute
Orlando, Florida, United States
Gulfcoast Oncology Associates
St. Petersburg, Florida, United States
University Cancer & Blood Center, LLC
Athens, Georgia, United States
Central Indiana Cancer Centers
Indianapolis, Indiana, United States
Kansas City Cancer Center
Overland Park, Kansas, United States
Wichita Community Clinical Oncology Program
Wichita, Kansas, United States
Center for Cancer & Blood Disorders
Bethesda, Maryland, United States
St. Louis Cancer & Breast Institute
St Louis, Missouri, United States
New York Oncology Hematology, P.C. NYOH Latham
Troy, New York, United States
Raleigh Hematology Oncology Associates
Cary, North Carolina, United States
Aultman Cancer Center
Canton, Ohio, United States
Sarah Cannon Oncology Hematology Care, Inc
Cincinnati, Ohio, United States
Oncology Associates of Oregon, PC
Eugene, Oregon, United States
Medical Oncology Associates of Wyorning Valley, PC
Kingston, Pennsylvania, United States
Chattanooga Oncology and Hematology Assoicates, PC
Chattanooga, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Texas Oncology, P.A.
Bedford, Texas, United States
Center for Oncology Research and Treatment, PA
Dallas, Texas, United States
Texas Cancer Center ( Medical City Dallas Hospital)
Dallas, Texas, United States
Texas Oncology Presbyterian Hospital
Dallas, Texas, United States
Texas Oncology Sammons Cancer Center
Dallas, Texas, United States
Texas Oncology Texas Oncology PA
Dallas, Texas, United States
Texas Cancer Center Denton
Denton, Texas, United States
El Paso Cancer Treatment Ctr-East
El Paso, Texas, United States
Texas Oncology, P.A.
Fort Worth, Texas, United States
San Antonio Tumor and Blood Clinic
Fredericksburg, Texas, United States
MD Anderson Cancer Center/University of Texas
Houston, Texas, United States
Longview Cancer Center
Longview, Texas, United States
South Texas Cancer Center- McAllen
McAllen, Texas, United States
Allison Cancer Center
Midland, Texas, United States
Texas Cancer Center- Sherman
Sherman, Texas, United States
Tyler Cancer Center
Tyler, Texas, United States
Waco Cancer and Research Center
Waco, Texas, United States
Virginia Cancer Specialists, PC
Fairfax, Virginia, United States
Northwest Cancer Specialists, P.C.
Vancover, Washington, United States
Novartis Investigative Site
Garran, Australian Capital Territory, Australia
Novartis Investigative Site
Port Macquarie, New South Wales, Australia
Novartis Investigative Site
Randwick, New South Wales, Australia
Novartis Investigative Site
Sydney, New South Wales, Australia
Novartis Investigative Site
Tweed Heads, New South Wales, Australia
Novartis Investigative Site
Waratah, New South Wales, Australia
Novartis Investigative Site
Nambour, Queensland, Australia
Novartis Investigative Site
Redcliff, Queensland, Australia
Novartis Investigative Site
Adelaide, South Australia, Australia
Novartis Investigative Site
Toorak Gardens, South Australia, Australia
Novartis Investigative Site
Box Hill, Victoria, Australia
Novartis Investigative Site
East Bentleigh, Victoria, Australia
Novartis Investigative Site
Epping, Victoria, Australia
Novartis Investigative Site
Footscray, Victoria, Australia
Novartis Investigative Site
Franston, Victoria, Australia
Novartis Investigative Site
Malvern, Victoria, Australia
Novartis Investigative Site
Parkville, Victoria, Australia
Novartis Investigative Site
Wodonga, Victoria, Australia
Novartis Investigative Site
Nedlands, Western Australia, Australia
Novartis Investigative Site
Perth, Western Australia, Australia
Novartis Investigative Site
Perth, Western Australia, Australia
Novartis Investigative Site
Auckland, , Australia
Novartis Investigative Site
Dunedin, , Australia
Novartis Investigative Site
Hamilton, , Australia
Novartis Investigative Site
Graz, Austria, Austria
Novartis Investigative Site
Vienna, Austria, Austria
Novartis Investigative Site
Wels, Austria, Austria
Novartis Investigative Site
Feldkirch, , Austria
Novartis Investigative Site
Friesach, , Austria
Novartis Investigative Site
Graz, , Austria
Novartis Investigative Site
Güssing, , Austria
Novartis Investigative Site
Innsbruck, , Austria
Novartis Investigative Site
Leoben, , Austria
Novartis Investigative Site
Linz, , Austria
Novartis Investigative Site
Linz, , Austria
Novartis Investigative Site
Salzburg, , Austria
Novartis Investigative Site
Vienna, , Austria
Novartis Investigative Site
Vienna, , Austria
Novartis Investigative Site
Villach, , Austria
Novartis Investigative Site
Wiener Neustadt, , Austria
Novartis Investigative Site
Aalst, , Belgium
Novartis Investigative Site
Antwerp, , Belgium
Novartis Investigative Site
Bonheiden, , Belgium
Novartis Investigative Site
Brasschaat, , Belgium
Novartis Investigative Site
Bruges, , Belgium
Novartis Investigative Site
Brussels, , Belgium
Novartis Investigative Site
Ghent, , Belgium
Novartis Investigative Site
Libramont, , Belgium
Novartis Investigative Site
Liège, , Belgium
Novartis Investigative Site
Turnhout, , Belgium
Novartis Investigative Site
Verviers, , Belgium
Novartis Investigative Site
Wilrijk, , Belgium
Novartis Investigative Site
Newmarket, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Québec, Quebec, Canada
Novartis Investigative Site
Regina, Saskatchewan, Canada
Novartis Investigative Site
Saskatoon, Saskatchewan, Canada
Novartis Investigative Site
Tianjin, Tianjin Municipality, China
Novartis Investigative Site
Beijing, , China
Novartis Investigative Site
Guangzhou, , China
Novartis Investigative Site
Shanghai, , China
Novartis Investigative Site
Aalborg, Denmark, Denmark
Novartis Investigative Site
Copenhagen, , Denmark
Novartis Investigative Site
Herlev, , Denmark
Novartis Investigative Site
Herning, , Denmark
Novartis Investigative Site
Hillerød, , Denmark
Novartis Investigative Site
Næstved, , Denmark
Novartis Investigative Site
Odense C, , Denmark
Novartis Investigative Site
Roskilde, , Denmark
Novartis Investigative Site
Vejle, , Denmark
Novartis Investigative Site
Viborg, , Denmark
Novartis Investigative Site
Angers, , France
Novartis Investigative Site
Caen, , France
Novartis Investigative Site
Créteil, , France
Novartis Investigative Site
Le Chesnay, , France
Novartis Investigative Site
Lyon, , France
Novartis Investigative Site
Marseille, , France
Novartis Investigative Site
Montbéliard, , France
Novartis Investigative Site
Montpellier, , France
Novartis Investigative Site
Nice, , France
Novartis Investigative Site
Perpignan, , France
Novartis Investigative Site
Périgueux Cédex, , France
Novartis Investigative Site
Rennes, , France
Novartis Investigative Site
Strasbourg, , France
Novartis Investigative Site
Toulouse, , France
Novartis Investigative Site
Kiel, Germany, Germany
Novartis Investigative Site
Amberg, , Germany
Novartis Investigative Site
Bayreuth, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Bremen, , Germany
Novartis Investigative Site
Düsseldorf, , Germany
Novartis Investigative Site
Erlangen, , Germany
Novartis Investigative Site
Essen, , Germany
Novartis Investigative Site
Frankfurt, , Germany
Novartis Investigative Site
Freiburg im Breisgau, , Germany
Novartis Investigative Site
Freiburg im Breisgau, , Germany
Novartis Investigative Site
Halle, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Homburg, , Germany
Novartis Investigative Site
Jena, , Germany
Novartis Investigative Site
Lübeck, , Germany
Novartis Investigative Site
Lüneburg, , Germany
Novartis Investigative Site
Magdeburg, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Offenbach, , Germany
Novartis Investigative Site
Regensburg, , Germany
Novartis Investigative Site
Trier, , Germany
Novartis Investigative Site
Tübingen, , Germany
Novartis Investigative Site
Ulm, , Germany
Novartis Investigative Site
Wiesbaden, , Germany
Novartis Investigative Site
Wiesbaden, , Germany
Novartis Investigative Site
Witten, , Germany
Novartis Investigative Site
Galway, Ireland, Ireland
Novartis Investigative Site
Cork, , Ireland
Novartis Investigative Site
Dublin, , Ireland
Novartis Investigative Site
Dublin, , Ireland
Novartis Investigative Site
Letterkenny, , Ireland
Novartis Investigative Site
Limerick, , Ireland
Novartis Investigative Site
Jerusalem, , Israel
Novartis Investigative Site
Rehovot, , Israel
Novartis Investigative Site
Tel Aviv, , Israel
Novartis Investigative Site
Tel Litwinsky, , Israel
Novartis Investigative Site
Montevarchi, AR, Italy
Novartis Investigative Site
Bari, BA, Italy
Novartis Investigative Site
Biella, BI, Italy
Novartis Investigative Site
Bologna, BO, Italy
Novartis Investigative Site
Chieti, CH, Italy
Novartis Investigative Site
Catania, CT, Italy
Novartis Investigative Site
Antella - Bagno A Ripoli, FI, Italy
Novartis Investigative Site
Forlì, FO, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Modena, MO, Italy
Novartis Investigative Site
Aviano, PN, Italy
Novartis Investigative Site
Parma, PR, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Castelfranco Veneto, TV, Italy
Novartis Investigative Site
Udine, UD, Italy
Novartis Investigative Site
Verona, VR, Italy
Novartis Investigative Site
Fermo, , Italy
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Matsuyama, Ehime, Japan
Novartis Investigative Site
Fukuoka, Fukuoka, Japan
Novartis Investigative Site
Kitakyushu, Fukuoka, Japan
Novartis Investigative Site
Maebashi, Gunma, Japan
Novartis Investigative Site
Sapporo, Hokkaido, Japan
Novartis Investigative Site
Isehara, Kanagawa, Japan
Novartis Investigative Site
Kawasaki, Kanagawa, Japan
Novartis Investigative Site
Yokohama, Kanagawa, Japan
Novartis Investigative Site
Kyoto, Kyoto, Japan
Novartis Investigative Site
Osaka, Osaka, Japan
Novartis Investigative Site
Suita, Osaka, Japan
Novartis Investigative Site
Kitaadachi-gun, Saitama, Japan
Novartis Investigative Site
Shizuoka, Shizuoka, Japan
Novartis Investigative Site
Shimotsuke, Tochigi, Japan
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan
Novartis Investigative Site
Chuo-ku, Tokyo, Japan
Novartis Investigative Site
Chuo-ku, Tokyo, Japan
Novartis Investigative Site
Koto, Tokyo, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, Japan
Novartis Investigative Site
Eindhoven, , Netherlands
Novartis Investigative Site
Enschede, , Netherlands
Novartis Investigative Site
Nijmegen, , Netherlands
Novartis Investigative Site
Rotterdam, , Netherlands
Novartis Investigative Site
Veldhoven, , Netherlands
Novartis Investigative Site
Skien, , Norway
Novartis Investigative Site
Goyang-si, Gyeonggi-do, South Korea
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Alicante, Alicante, Spain
Novartis Investigative Site
Málaga, Andalusia, Spain
Novartis Investigative Site
Seville, Andalusia, Spain
Novartis Investigative Site
Sabadell, Barcelona, Spain
Novartis Investigative Site
Santander, Cantabria, Spain
Novartis Investigative Site
A Coruña, Galicia, Spain
Novartis Investigative Site
A Coruña, Galicia, Spain
Novartis Investigative Site
Madrid, Madrid, Spain
Novartis Investigative Site
Valencia, Valencia, Spain
Novartis Investigative Site
Zaragoza, Zaragoza, Spain
Novartis Investigative Site
Lund, , Sweden
Novartis Investigative Site
Stockholm, , Sweden
Novartis Investigative Site
Uppsala, , Sweden
Novartis Investigative Site
Chur, , Switzerland
Novartis Investigative Site
Lucerne, , Switzerland
Novartis Investigative Site
Schaffhausen, , Switzerland
Novartis Investigative Site
Winterthur, , Switzerland
Novartis Investigative Site
Hull, East Yorkshire, United Kingdom
Novartis Investigative Site
Glasgow, Glasgow, United Kingdom
Novartis Investigative Site
Northwood, Middlesex, United Kingdom
Novartis Investigative Site
Belfast, , United Kingdom
Novartis Investigative Site
Bournemouth, , United Kingdom
Novartis Investigative Site
Bristol, , United Kingdom
Novartis Investigative Site
Chelmsford, , United Kingdom
Novartis Investigative Site
Colchester, , United Kingdom
Novartis Investigative Site
Liverpool, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
Manchester, , United Kingdom
Novartis Investigative Site
Merseyside, , United Kingdom
Novartis Investigative Site
Plymouth, , United Kingdom
Novartis Investigative Site
Rhyl, , United Kingdom
Novartis Investigative Site
Sheffiled, , United Kingdom
Novartis Investigative Site
Shrewsbury, , United Kingdom
Novartis Investigative Site
Surrey, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005-004263-35
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
EUDRACT number 2005-004263-35
Identifier Type: REGISTRY
Identifier Source: secondary_id
CFEM345D2411
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.